Type 2 Diabetes Bioactive Compounds in Rosemary and Mexican Oregano - - Chromatography Online
Type 2 Diabetes Bioactive Compounds in Rosemary and Mexican Oregano


The Column
Volume 10, Issue 15, pp. 5

A new study published in the Journal of Agricultural and Food Chemistry highlights the potential use of rosemary and oregano in the management of Type 2 diabetes mellitus (T2DM) (1). T2DM is typically managed using a combination of diet control and drugs to inhibit specific targets associated with T2DM; however, herbs contain high levels of bioactive compounds that could have the same therapeutic effect.

The ability of four herbs — Greek oregano (Origanum vulgare), marjoram (Origanum majorana), rosemary (Rosmarinus officinalis), and Mexican oregano (Lippia graveolens) — to inhibit dipeptidyl peptidase IV (DPP-IV), a drug target of T2DM, was investigated. Mexican oregano and rosemary was shown by liquid chromatography coupled to electrospray ionization mass spectrometry (LC–ESI–MS) analysis to contain the phytochemicals eriodictyol, naringenin, hispidulin, cirsimaritin, and carnosol. In biochemical inhibition assays, cirsimaritin, hispidulin, and naringenin were the most effective DPP-IV inhibitors.

According to the authors this work demonstrates the potential use of herbs in the management of T2DM but further work is needed. — B.D.

Reference
1.         A.M. Bower, L.M.R. Hernandez, M.A. Berhow, and E.G. de Mejiya, Journal of Agricultural and Food Chemistry 62, 6147−6158 (2014).

This story originally appeared in The Column. Click here to view that issue.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: The Column,
Click here